Several WNT pathway genes were significantly differentially expressed in AFX including WISP1, FZD1, PORCN, and SFRP. These mutations and dysregulated genes suggest that FAT1 and WNT signaling may play a role in the development or progression of AFX. The gene discussed is FZD1; the disease is acquired factor X deficiency.